List Trials for Newly Diagnosed Sarcoma

Sarcoma

 

Oral Regorafenib for Refractory Liposarcoma, Osteosarcoma, and Ewing Sarcomas (20132286)
A Blanket Protocol to Study Oral Regorafenib in Patients With Refractory Liposarcoma, Osteogenic Sarcoma, and Ewing/Ewing-like Sarcomas

Investigator: Elizabeth Loggers, MD;   Conditions: Sarcoma; Liposarcoma; Sarcoma, Ewing; Osteosarcoma;    Status: Recruiting;   Study ID: NCT02048371